Avra Medical (OTC: AVMR) interview with Barry Cohen, CEO. Barry discusses the technology Avra is developing for fully autonomous robotic surgery. The company's goal is to receive FDA approval and enter commercialization by 2020, with an initial focus on automated dermatological surgery procedures.
. . .
This content is available to members only.
If you are an existing member, please LOGIN
Note a member? Sign up for a FREE account ($89 per month value), and get immediate access. Free offer expires March 29, 2019.
Register New Account
Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2